ACLSHIGH SIGNALFINANCIAL10-K

ACLS experienced a severe financial deterioration with operating income plummeting 43% and revenue declining 18% year-over-year, indicating significant operational challenges in the semiconductor equipment market.

The dramatic decline in operating leverage suggests ACLS is struggling with fixed cost absorption as demand weakened substantially. Despite maintaining gross margins, the company's profitability collapsed due to lower volumes, which is particularly concerning for a capital equipment manufacturer where operating leverage typically drives returns.

Comparing 2026-02-26 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

ACLS showed broad-based financial weakness with revenue falling 18% to $839M while operating income crashed 43% to $119M, demonstrating severe operating deleverage. The company maintained cash levels through doubled share buybacks ($121M vs $61M) despite weaker cash generation, while inventory increased 17% against declining receivables, suggesting demand softness and potential working capital management challenges. The overall picture signals a cyclical downturn hitting profitability harder than revenue, typical of capital equipment companies facing semiconductor market headwinds.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+100.2%
$60.5M$121.1M

Share repurchases increased 100.2% — management returning capital, signals confidence in intrinsic value.

Operating Income
P&L
-43.4%
$210.8M$119.3M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-40.2%
$201.0M$120.2M

Net income declined 40.2% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
+17.8%
$123.5M$145.5M

Cash grew 17.8% — improving liquidity position supports investment and shareholder returns.

Revenue
P&L
-17.6%
$1.0B$839.0M

Revenue softened 17.6% — monitor whether this is cyclical or structural.

Gross Profit
P&L
-17.1%
$454.7M$376.8M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Accounts Receivable
Balance Sheet
-17.1%
$203.1M$168.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Inventory
Balance Sheet
+16.6%
$282.2M$329.0M

Inventory built 16.6% — monitor whether demand supports this build or if write-downs may follow.

Current Assets
Balance Sheet
-16.1%
$1.1B$943.2M

Current assets declined 16.1% — monitor working capital adequacy and short-term liquidity.

Operating Cash Flow
Cash Flow
-16%
$140.8M$118.3M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-28
ADDED
The ion implantation business represented 98.2% of our revenue in 2025, with the remaining 1.8% of revenue derived from aftermarket sales associated with other legacy processing systems.
Revenue for 2025 was $839.0 million, compared to $1,017.9 million in 2024.
Systems revenue for 2025 was $571.0 million, compared to $782.6 million in 2024.
Gross margin percent for 2025 was 44.9% compared to 44.7% in 2024.
Operating profit for 2025 was $119.3 million, compared to $210.8 million in 2024.
+7 more — sign up free →
REMOVED
The ion implantation business represented 98.3% of our revenue in 2024, with the remaining 1.7% of revenue derived from aftermarket sales associated with other legacy processing systems.
Revenue for 2024 was $1,017.9 million, compared to $1,130.6 million in 2023.
Systems revenue for 2024 was $782.6 million, compared to $883.6 million in 2023.
Gross margin percent for 2024 was 44.7% compared to 43.5% in 2023.
Operating profit for 2024 was $210.8 million, compared to $265.8 million in 2023.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →